Profil
Andreas Buchbender is currently working as a Portfolio Manager at Medical Strategy GmbH since 2023.
Previously, he worked as a Scientific Assistant at Max Planck Institut für Pflanzenzüchtungsforschung from 2011 to 2013.
Dr. Buchbender completed his undergraduate and graduate degrees at the University of Hannover in 2016 and 2017 respectively.
He obtained his doctorate degree from The Johannes Gutenberg University of Mainz in 2021.
Aktive Positionen von Andreas Buchbender
| Unternehmen | Position | Beginn |
|---|---|---|
Medical Strategy GmbH
Medical Strategy GmbH Investment ManagersFinance MS is an active growth-oriented investor and manages portfolios invested in global equity with a long-term outlook. The firm focuses on mid- and small-cap companies from the healthcare sector, including pharma, emerging pharma, biotech, genomics, medtech, drug delivery and e-health. MS uses computer models to continuously screen a selection of 700-800 listed companies as well as pre-IPOs for which they systematically collect data in a proprietary database. This information is completed by both in-house and third-party fundamental research | Analyst-Equity | 01.11.2020 |
Ehemalige bekannte Positionen von Andreas Buchbender
| Unternehmen | Position | Ende |
|---|---|---|
Max Planck Institut für Pflanzenzüchtungsforschung
Max Planck Institut für Pflanzenzüchtungsforschung Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2013 |
Ausbildung von Andreas Buchbender
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Medical Strategy GmbH
Medical Strategy GmbH Investment ManagersFinance MS is an active growth-oriented investor and manages portfolios invested in global equity with a long-term outlook. The firm focuses on mid- and small-cap companies from the healthcare sector, including pharma, emerging pharma, biotech, genomics, medtech, drug delivery and e-health. MS uses computer models to continuously screen a selection of 700-800 listed companies as well as pre-IPOs for which they systematically collect data in a proprietary database. This information is completed by both in-house and third-party fundamental research | Finance |
University of Hannover
University of Hannover Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johannes Gutenberg University of Mainz
The Johannes Gutenberg University of Mainz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Max Planck Institut für Pflanzenzüchtungsforschung
Max Planck Institut für Pflanzenzüchtungsforschung Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















